Newly Diagnosed Multiple Myeloma Withdrawn Phase 4 Trials for Lenalidomide (DB00480)

Also known as: Newly Diagnosed Multiple Myeloma (NDMM) / Newly Diagnosed, Multiple Myeloma / Multiple Myeloma, Newly Diagnosed

IndicationStatusPhase
DBCOND0036257 (Newly Diagnosed Multiple Myeloma)Withdrawn4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04348006Assessment of Bortezomib (Alvocade ®) Efficacy and Safety in Newly Diagnosed Multiple Myeloma PatientsTreatment